The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam
Abstract
In a previous study, rats treated chronically with flurazepam were tolerant to the anticonvulsant action of some benzodiazepines (BZs), but not others (34). To determine if this differential crosstolerance was unique to flurazepam, rats were treated chronically with diazepam or midazolam, and tested for tolerance to the anticonvulsant actions of diazepam, midazolam, clonazepam, and clobazam. Regional benzodiazepine receptor binding in brain was also studied. In contrast to previous findings with flurazepam, 1 week treatment with diazepam or with midazolam did not cause tolerance. Rats treated with diazepam for 3 weeks were tolerant to diazepam, clonazepam, clobazam, and midazolam. In contrast, rats treated 3 weeks with midazolam were tolerant to diazepam and midazolam, but not clobazam or clonazepam. Neither diazepam nor midazolam treatment for 3 weeks altered BZ binding in cerebral cortex, cerebellum, or hippocampus. The effects of chronic BZ treatment depended not only on the BZ given chronically, but also on the BZ used to evaluate these effects, suggesting drug-specific interactions of different BZs with their receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ramsey-Williams et al. (187) demonstrated that after 3 weeks of diazepam treatment, rats developed cross-tolerance to the anticonvulsant effects of clobazam, clonazepam and midazolam.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [187]
In the citing paper
“Rats treated with midazolam for 3 weeks developed cross-tolerance to diazepam but not to clobazam or clonazepam.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [187]
In the citing paper
“The authors suggested that differences in tolerance and crosstolerance could result from differential regulation of receptor subunit expression by each drug and from differences between the drugs in their interactions with receptors at the time of testing.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [187]
In the citing paper
“Cross-tolerance between BZDs occurs and appears to be drug specific.”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [187]
In the citing paper
“Li et al. (198) suggested that down-regulation of BZD receptor binding sites could not fully explain the development of tolerance because tolerance to some BZDs has been observed even when no changes in BZDreceptor binding were noted (187).”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [187]
Citations
Cites
Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family
Schofield, P. R., Darlison, M. G., Fujita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., et al. (1987) · Nature · doi:10.1038/328221a0 · Cited by 1,622
The effect of subunit composition of rat brain GABAA receptors on channel function
Sigel, E., Baur, R., Trube, G., Möhler, H., & Malherbe, P. (1990) · Neuron · doi:10.1016/0896-6273(90)90224-4 · Cited by 596
Structural and functional basis for GABAA receptor heterogeneity
Levitan, E. S., Schofield, P. R., Burt, D. R., Rhee, L. M., Wisden, W., Köhler, M., Fujita, N., Rodriguez, H. F., Stephenson, A., Darlison, M. G., et al. (1988) · Nature · doi:10.1038/335076a0 · Cited by 589
Functional properties of recombinant rat GABAA receptors depend upon subunit composition
Verdoorn, T. A., Draguhn, A., Ymer, S., Seeburg, P. H., & Sakmann, B. (1990) · Neuron · doi:10.1016/0896-6273(90)90145-6 · Cited by 553
Puia, G., Vicini, S., Seeburg, P. H., & Costa, E. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)00452-3 · Cited by 342
Miller, L. G., Greenblatt, D. J., Barnhill, J. G., & Shader, R. I. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20998-3 · Cited by 220
Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding
Rosenberg, H. C., & Chiu, T. H. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90356-3 · Cited by 135
Self-citationChan, C., & Farb, D. H. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02365.1985 · Cited by 121
Effects of continuous diazepam administration on GABAA subunit mRNA in rat brain
Heninger, C., Saito, N., Tallman, J. F., Garrett, K. M., Vitek, M. P., Duman, R. S., & Gallager, D. W. (1990) · Journal of Molecular Neuroscience · doi:10.1007/bf02876917 · Cited by 118
Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats
File, S. E. (1981) · Psychopharmacology · doi:10.1007/bf00422410 · Cited by 117
Cited by
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Shafer, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199805000-00034 · Cited by 398
Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus
Claassen, J., Hirsch, L. J., Emerson, R. G., Bates, J. E., Thompson, T. B., & Mayer, S. A. (2001) · Neurology · doi:10.1212/wnl.57.6.1036 · Cited by 220
“30 min during any 24-h period 4 (15) 10 (31) 4 (13)”
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
“Decreased number of BZ binding sites after long-term BZ treatment has been observed in some studies (Rosenberg and Chiu, 1979; Miller et al., 1988, 1989), whereas no change has been found in most studies (Gallager et al., 1984; Heninger and Gallager, 1988; Ramsey-Williams et al., 1994).”
BackgroundHutchinson, M. A., Smith, P. F., & Darlington, C. L. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00011-1 · Cited by 95
Metadata
- Authors
- Ramsey-Williams, V. A., Wu, Y., & Rosenberg, H. C.
- Corresponding author
- Rosenberg, Howard C.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 1994-07
- Volume
- 48
- Issue
- 3
- Pages
- 765-772
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2062971299
- Cited by
- 31
- References
- 47
- Citations by year
- 2026: 1 · 2018: 1 · 2016: 1 · 2015: 1
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01da002194-21)
- National Institute on Drug Abuse (R01-DA-02194)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- benzodiazepine tolerance, diazepam, midazolam, clonazepam, clobazam, anticonvulsant activity, benzodiazepine binding, chronic drug administration, flurazepam
- MeSH terms
- Animals, Anticonvulsants, Binding, Competitive, Brain, Diazepam, Drug Tolerance, Male, Midazolam, Pentylenetetrazole, Radioligand Assay, Receptors, GABA-A, Seizures, Anti-Anxiety Agents, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam. https://app.cochat.ai/papers/10.1016/0091-3057(94)90344-1
- The paper
- Ramsey-Williams, V. A., Wu, Y., & Rosenberg, H. C. (1994). Comparison of anticonvulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/0091-3057(94)90344-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.